Institutional Manager · CIK 0001056807
BVF INC/IL
San Francisco, CA · File #028-06800
Latest AUM
$2.97B
Positions
41
Top-10 Concentration
62.8%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | PROTAGONIST THERAPEUTICS INC | 74366E102 | -2,560,916 | -$170.1M | $0 |
| EXITED | CIDARA THERAPEUTICS INC | 171757206 | -1,414,165 | -$135.4M | $0 |
| REDUCE | AXSOME THERAPEUTICS INC | AXSM | -441,000 | -$80.5M | +$29.8M |
| ADD | XENCOR INC | XNCR | +4,393,579 | +$67.3M | +$9.8M |
| REDUCE | SEPTERNA INC | SEPN | -2,295,008 | -$64.0M | +$36.4M |
| NEW | DISC MEDICINE INC | IRON | +650,000 | +$51.6M | $0 |
| REDUCE | REVOLUTION MEDICINES INC | RVMDW | -618,131 | -$49.2M | +$131.0M |
| NEW | INVIVYD INC | IVVD | +19,525,000 | +$48.2M | $0 |
| REDUCE | TYRA BIOSCIENCES INC | TYRA | -1,522,129 | -$40.0M | +$44.9M |
| EXITED | CELCUITY INC | 15102K100 | -658,421 | -$32.5M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202541 pos · $2.97B
- 13F HOLDINGS REPORTQ/E Sep 202546 pos · $2.47B
- 13F HOLDINGS REPORTQ/E Jun 202544 pos · $2.80B
- 13F HOLDINGS REPORTQ/E Mar 202551 pos · $2.45B
- 13F HOLDINGS REPORTQ/E Dec 202453 pos · $2.95B
- 13F HOLDINGS REPORTQ/E Sep 202455 pos · $3.42B
- 13F HOLDINGS REPORTQ/E Jun 202460 pos · $3.57B
- 13F HOLDINGS REPORTQ/E Mar 202462 pos · $3.64B
- 13F HOLDINGS REPORTQ/E Dec 202369 pos · $3.71B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | KYMERA THERAPEUTICS INC | KYMR | 5,502,710 | $428.2M | 14.41% |
| 2 | REVOLUTION MEDICINES INC | RVMDW | 3,356,782 | $267.4M | 9.00% |
| 3 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 19,751,284 | $260.3M | 8.76% |
| 4 | STRUCTURE THERAPEUTICS INC | GPCR | 3,479,022 | $242.0M | 8.15% |
| 5 | OLEMA PHARMACEUTICALS INC | OLMA | 5,295,893 | $132.4M | 4.46% |
| 6 | MIRUM PHARMACEUTICALS INC | MIRM | 1,495,290 | $118.1M | 3.98% |
| 7 | GH RESEARCH PLC | GHRS | 8,827,712 | $112.1M | 3.77% |
| 8 | XENCOR INC | XNCR | 7,133,720 | $109.2M | 3.68% |
| 9 | ZYMEWORKS INC | ZYME | 3,938,641 | $103.7M | 3.49% |
| 10 | PALVELLA THERAPEUTICS INC NE | PVLA | 879,009 | $92.0M | 3.10% |
| 11 | KURA ONCOLOGY INC | KURA | 8,617,162 | $89.5M | 3.01% |
| 12 | STOKE THERAPEUTICS INC | STOK | 2,265,674 | $71.9M | 2.42% |
| 13 | XOMA ROYALTY CORPORATION | XOMAP | 2,590,303 | $68.9M | 2.32% |
| 14 | ABIVAX SA | AAVXF | 508,031 | $68.5M | 2.31% |
| 15 | NEKTAR THERAPEUTICS | NKTR | 1,559,595 | $65.9M | 2.22% |
| 16 | AC IMMUNE SA | ACIU | 19,822,436 | $62.2M | 2.10% |
| 17 | MONTE ROSA THERAPEUTICS INC | GLUE | 3,835,886 | $60.1M | 2.02% |
| 18 | CULLINAN THERAPEUTICS INC | CGEM | 5,750,683 | $59.5M | 2.00% |
| 19 | TYRA BIOSCIENCES INC | TYRA | 2,127,665 | $55.9M | 1.88% |
| 20 | DISC MEDICINE INC | IRON | 650,000 | $51.6M | 1.74% |